NUVBNuvation Bio Inc.

$6.61

What is the market doing?

What the tape says about NUVB

Nuvation Bio Inc. is +128% over the past year while the S&P 500 is +20%: 107 points ahead of the market.

+128%

1-year return · S&P 500 +20%

vs 200-day average
+12%

vs 200-day average · a clear uptrend

RSI (14)
52

RSI (14) · neutral

Below its 52-week high
31%

Below its 52-week high

2024-08-15$1.66 – $9.54 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$6.61
1 monthS&P 500 −0.30%
+8.1%
1 yearS&P 500 +20%
+128%
5 yearsS&P 500 +85%
−21%
vs 50-day average$6.21
+6.4%
52-week high
$9.54
52-week low
$2.69
Annualised volatility
83%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$118K
Calendar-year price return
YearReturn
2026 (year to date)−26%
2025+237%
2024+76%
2023−21%
2022−77%
2021−27%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan62 of 6−10.0%
Feb62 of 6−4.5%
Mar63 of 6+8.4%
Apr63 of 6+1.1%
May64 of 6+1.5%
Jun62 of 6−4.0%
Jul64 of 6+8.0%
Aug63 of 6+1.1%
Sep73 of 7−3.4%
Oct61 of 6−1.6%
Nov63 of 6+16%
Dec64 of 6+6.1%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.